New Zealand –
- July net migration +4540 (+4270 prior)
- Short-term visitors +7% in July y/y
New Zealand –
Most Popular
Sponsored
CRISPR Therapeutics (CRSP) down 9% after offering. $4.6B cap, approved therapy, but $581M loss. Potential upside?
Tesla's $20B Terafab chip plant sparks debate: innovation or desperation? Watch valuation.
New $35M prediction market fund launches! Rivals unite, eyeing $10T volume potential. Risks loom from regulators.
Helium shortage sparks fibre optic cable risks, quadrupling spot prices. AI boom faces production constraints.
Airlines soar on falling oil prices; DRVN jumps 8.6% but remains volatile, down 20.2% YTD.
Vanguard sees 4-5% U.S. equity returns; high tech valuations & new entrants pose risks. Diversify!
TotalEnergies exits US offshore wind for $1B refund, pivots to fossil fuels. Valuation shift.
Sponsored
Must Read